Peter Schuld
Impact in
- Hematology top 5%
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
- Genetics top 10%
- Chronic Lymphocytic Leukemia Research
Papers in
- Hematology 14
- Chronic Myeloid Leukemia Treatments 14
- Genetics 9
- Chronic Lymphocytic Leukemia Research 9
- Co-authors
- François‐Xavier Mahon (4 shared papers)Mathiéu Molimard (3 shared papers)Stéphane Bouchet (2 shared papers)Coralie Bélanger (1 shared paper)R. Lassalle (1 shared paper)Karine Titier (1 shared paper)Nicholas Moore (1 shared paper)Verena Gotta (1 shared paper)
- Journals
- Blood (5 papers)HemaSphere (2 papers)Haematologica (1 paper)Cancer (1 paper)Leukemia Research (1 paper)
- Partner nations
- GermanySwitzerlandFrance
In The Last Decade
Peter Schuld
12 papers receiving 210 citations
Peers
Comparison fields: 5 of 41
- Hematology 145
- Genetics 91
- Rheumatology 43
- Pharmaceutical Science 16
- Gastroenterology 12
Countries citing papers authored by Peter Schuld
This map shows the geographic impact of Peter Schuld's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Schuld with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Schuld more than expected).
Fields of papers citing papers by Peter Schuld
This network shows the impact of papers produced by Peter Schuld. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Schuld. The network helps show where Peter Schuld may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Schuld, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 57 | |
| 2 | 2007 | 45 | |
| 3 | 2014 | 44 | |
| 4 | 2003 | 37 | |
| 5 | 2019 | 9 | |
| 6 | 2020 | 8 | |
| 7 | 2011 | 8 | |
| 8 | 2011 | 2 | |
| 9 | 2005 | 2 | |
| 10 | 2023 | 1 | |
| 11 | 2023 | 1 | |
| 12 | 2025 | 1 | |
| 13 | 2010 | 0 | |
| 14 | 2023 | 0 | |
| 15 | 2023 | 0 |
About Peter Schuld
Peter Schuld is a scholar working on Hematology, Genetics, Public Health, Environmental and Occupational Health, Organic Chemistry and Rheumatology, having authored 15 papers that have together received 215 indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (14 papers), Chronic Lymphocytic Leukemia Research (9 papers), Acute Lymphoblastic Leukemia research (4 papers), Eosinophilic Disorders and Syndromes (2 papers), Synthesis and Characterization of Heterocyclic Compounds (1 paper), Click Chemistry and Applications (1 paper), Streptococcal Infections and Treatments (1 paper) and Lymphoma Diagnosis and Treatment (1 paper). The work is most often cited by research in Hematology (145 citations), Genetics (91 citations), Rheumatology (43 citations), Pharmaceutical Science (16 citations) and Gastroenterology (12 citations). Peter Schuld has collaborated with scholars based in Germany, Switzerland and France. Frequent co-authors include François‐Xavier Mahon, Mathiéu Molimard, Stéphane Bouchet, Coralie Bélanger, R. Lassalle, Karine Titier, Nicholas Moore, Verena Gotta, Nicolas Widmer and Laurent A. Décosterd. Their work appears in journals such as Blood, HemaSphere, Haematologica, Cancer and Leukemia Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.